{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:19:49Z","timestamp":1793891989588,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04591-1","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T02:54:59Z","timestamp":1741316099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association of visceral adiposity index (VAI) with prognosis in patients with metabolic syndrome and heart failure with reduced ejection fraction"],"prefix":"10.1186","volume":"25","author":[{"given":"Meiyin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YueShengzi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"9","key":"4591_CR1","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke Statistics-2020 update: A report from the American heart association. Circulation. 2020;141(9):e139\u2013596.","journal-title":"Circulation"},{"issue":"20","key":"4591_CR2","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","volume":"70","author":"KS Shah","year":"2017","unstructured":"Shah KS, Xu H, Matsouaka RA, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-Year outcomes. J Am Coll Cardiol. 2017;70(20):2476\u201386.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4591_CR3","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","volume":"42","author":"JB Braunstein","year":"2003","unstructured":"Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42(7):1226\u201333.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4591_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3892\/etm.2014.1673","volume":"8","author":"M Motie","year":"2014","unstructured":"Motie M, Evangelista LS, Horwich T, et al. Association between inflammatory biomarkers and adiposity in obese patients with heart failure and metabolic syndrome. Exp Ther Med. 2014;8(1):181\u20136.","journal-title":"Exp Ther Med"},{"issue":"4","key":"4591_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ehf2.12120","volume":"3","author":"V Nagarajan","year":"2016","unstructured":"Nagarajan V, Kohan L, Holland E, Keeley EC, Mazimba S. Obesity paradox in heart failure: a heavy matter. ESC Heart Fail. 2016;3(4):227\u201334.","journal-title":"ESC Heart Fail"},{"issue":"9","key":"4591_CR6","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.3390\/jcm12093341","volume":"12","author":"J Stencel","year":"2023","unstructured":"Stencel J, Alai HR, Dhore-Patil A, Urina-Jassir D, Le Jemtel TH, Obesity. Preserved ejection fraction heart failure, and left ventricular remodeling. J Clin Med. 2023;12(9):3341.","journal-title":"J Clin Med"},{"issue":"4","key":"4591_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tcm.2015.10.004","volume":"26","author":"SM Grundy","year":"2016","unstructured":"Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364\u201373.","journal-title":"Trends Cardiovasc Med"},{"key":"4591_CR8","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.5888\/pcd14.160287","volume":"14","author":"JX Moore","year":"2017","unstructured":"Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race\/ethnicity and sex in the united States, National health and nutrition examination survey, 1988\u20132012. Prev Chronic Dis. 2017;14:E24.","journal-title":"Prev Chronic Dis"},{"issue":"3","key":"4591_CR9","doi-asserted-by":"publisher","first-page":"e0194490","DOI":"10.1371\/journal.pone.0194490","volume":"13","author":"SE Lee","year":"2018","unstructured":"Lee SE, Han K, Kang YM, et al. Trends in the prevalence of metabolic syndrome and its components in South Korea: findings from the Korean National health insurance service database (2009\u20132013). PLoS ONE. 2018;13(3):e0194490.","journal-title":"PLoS ONE"},{"issue":"1","key":"4591_CR10","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1186\/s12889-022-14263-w","volume":"22","author":"Y Huang","year":"2022","unstructured":"Huang Y, Zhang L, Wang Z, et al. The prevalence and characteristics of metabolic syndrome according to different definitions in China: a nationwide cross-sectional study, 2012\u20132015. BMC Public Health. 2022;22(1):1869.","journal-title":"BMC Public Health"},{"issue":"2","key":"4591_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3724\/SP.J.1263.2012.01172","volume":"9","author":"DL Sun","year":"2012","unstructured":"Sun DL, Wang JH, Jiang B, et al. Metabolic syndrome vs. its components for prediction of cardiovascular mortality: A cohort study in Chinese elderly adults. J Geriatr Cardiol. 2012;9(2):123\u20139.","journal-title":"J Geriatr Cardiol"},{"issue":"5","key":"4591_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/joim.12728","volume":"284","author":"AC Sletten","year":"2018","unstructured":"Sletten AC, Peterson LR, Schaffer JE. Manifestations and mechanisms of myocardial lipotoxicity in obesity. J Intern Med. 2018;284(5):478\u201391.","journal-title":"J Intern Med"},{"issue":"7121","key":"4591_CR13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840\u20136.","journal-title":"Nature"},{"issue":"6","key":"4591_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.amjmed.2018.02.002","volume":"131","author":"JJ Lee","year":"2018","unstructured":"Lee JJ, Pedley A, Hoffmann U, Massaro JM, Levy D, Long MT. Visceral and intrahepatic fat are associated with cardiometabolic risk factors above other ectopic fat depots: the Framingham heart study. Am J Med. 2018;131(6):684\u2013e69212.","journal-title":"Am J Med"},{"issue":"5","key":"4591_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jim-2018-000722","volume":"66","author":"M Borga","year":"2018","unstructured":"Borga M, West J, Bell JD, et al. Advanced body composition assessment: from body mass index to body composition profiling. J Investig Med. 2018;66(5):1\u20139.","journal-title":"J Investig Med"},{"issue":"4","key":"4591_CR16","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC, Giordano C, Galia M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920\u20132.","journal-title":"Diabetes Care"},{"issue":"16","key":"4591_CR17","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti KG","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"issue":"1","key":"4591_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jchf.2018.10.010","volume":"7","author":"HP Brunner-La Rocca","year":"2019","unstructured":"Brunner-La Rocca HP, Linssen GC, Smeele FJ, van Drimmelen AA, Schaafsma HJ, Westendorp PH, et al. Contemporary drug treatment of chronic heart failure with reduced ejection fraction: the CHECK-HF registry. JACC Heart Fail. 2019;7(1):13\u201321.","journal-title":"JACC Heart Fail"},{"issue":"4","key":"4591_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4274\/balkanmedj.galenos.2022.2022-3-97","volume":"39","author":"Y \u00c7avu\u015fo\u011flu","year":"2022","unstructured":"\u00c7avu\u015fo\u011flu Y, Altay H, Aras D, et al. Cost-of-disease of heart failure in Turkey: A Delphi Panel-based analysis of direct and indirect costs. Balkan Med J. 2022;39(4):282\u20139.","journal-title":"Balkan Med J"},{"issue":"4","key":"4591_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.33963\/v.phj.99549","volume":"82","author":"JT Niedziela","year":"2024","unstructured":"Niedziela JT, Rozentryt P, Nowak J, et al. Characteristics and outcomes for patients with heart failure diagnosed according to the universal definition and classification of heart failure. Data from a single-center registry. Kardiol Pol. 2024;82(4):391\u20137.","journal-title":"Kardiol Pol"},{"key":"4591_CR21","doi-asserted-by":"crossref","unstructured":"Hu Y, Wang X, Xiao S et al. Development and validation of a nomogram model for predicting the risk of readmission in patients with heart failure with reduced ejection fraction within 1 year. Cardiovasc Ther. 2022; 4143173.","DOI":"10.1155\/2022\/4143173"},{"issue":"9","key":"4591_CR22","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/ejhf.2962","volume":"25","author":"M Yang","year":"2023","unstructured":"Yang M, Kondo T, Adamson C, et al. Impact of comorbidities on health status measured using the Kansas City cardiomyopathy questionnaire in patients with heart failure with reduced and preserved ejection fraction. Eur J Heart Fail. 2023;25(9):1606\u201318.","journal-title":"Eur J Heart Fail"},{"issue":"10120","key":"4591_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","volume":"391","author":"N Conrad","year":"2018","unstructured":"Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572\u201380.","journal-title":"Lancet"},{"issue":"25","key":"4591_CR24","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","volume":"381","author":"ZJ Ward","year":"2019","unstructured":"Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. State-Level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440\u201350.","journal-title":"N Engl J Med"},{"issue":"8","key":"4591_CR25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","volume":"6","author":"N Savji","year":"2018","unstructured":"Savji N, Meijers WC, Bartz TM, et al. The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail. 2018;6(8):701\u20139.","journal-title":"JACC Heart Fail"},{"issue":"9","key":"4591_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0002-9149(92)90739-L","volume":"70","author":"EK Kasper","year":"1992","unstructured":"Kasper EK, Hruban RH, Baughman KL. Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. Am J Cardiol. 1992;70(9):921\u20134.","journal-title":"Am J Cardiol"},{"issue":"6","key":"4591_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/CIRCRESAHA.119.312321","volume":"126","author":"AJ Mouton","year":"2020","unstructured":"Mouton AJ, Li X, Hall ME, Hall JE. Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation. Circ Res. 2020;126(6):789\u2013806.","journal-title":"Circ Res"},{"issue":"4","key":"4591_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jacc.2009.07.029","volume":"55","author":"TB Horwich","year":"2010","unstructured":"Horwich TB, Fonarow GC. Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. J Am Coll Cardiol. 2010;55(4):283\u201393.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4591_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00395-014-0445-6","volume":"109","author":"JN Simon","year":"2014","unstructured":"Simon JN, Chowdhury SA, Warren CM, et al. Ceramide-mediated depression in cardiomyocyte contractility through PKC activation and modulation of myofilament protein phosphorylation. Basic Res Cardiol. 2014;109(6):445.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"4591_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/14756366.2018.1542387","volume":"34","author":"CO de Lima","year":"2019","unstructured":"de Lima CO, Piuvezam V, Leal Lima Maciel G, Heloneida de Ara\u00fajo Morais B. Trypsin inhibitors: promising candidate satietogenic proteins as complementary treatment for obesity and metabolic disorders. J Enzyme Inhib Med Chem. 2019;34(1):405\u201319.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"14","key":"4591_CR31","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.119.042770","volume":"141","author":"JJ Rayner","year":"2020","unstructured":"Rayner JJ, Peterzan MA, Watson WD, et al. Myocardial energetics in obesity: enhanced ATP delivery through creatine kinase with blunted stress response. Circulation. 2020;141(14):1152\u201363.","journal-title":"Circulation"},{"issue":"1","key":"4591_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/ejcn.2009.68","volume":"64","author":"R Huxley","year":"2010","unstructured":"Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk\u2013a review of the literature. Eur J Clin Nutr. 2010;64(1):16\u201322.","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"4591_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ejhf.521","volume":"18","author":"C Russo","year":"2016","unstructured":"Russo C, Sera F, Jin Z, et al. Abdominal adiposity, general obesity, and subclinical systolic dysfunction in the elderly: A population-based cohort study. Eur J Heart Fail. 2016;18(5):537\u201344.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"4591_CR34","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.3390\/nu15102254","volume":"15","author":"GA Bray","year":"2023","unstructured":"Bray GA, Beyond BMI. Nutrients. 2023;15(10):2254.","journal-title":"Nutrients"},{"issue":"9","key":"4591_CR35","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.5551\/jat.63081","volume":"29","author":"K Yamagishi","year":"2022","unstructured":"Yamagishi K, Iso H, Sairenchi T, Irie F, Takizawa N, Koba A, et al. Diabetes mellitus modifies the association of serum triglycerides with ischemic cardiovascular disease mortality: the Ibaraki prefectural health study (IPHS). J Atheroscler Thromb. 2022;29(9):1319\u201327.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"4591_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5551\/jat.13201","volume":"20","author":"F Sbrana","year":"2013","unstructured":"Sbrana F, Puntoni M, Bigazzi F, Landi P, Sampietro T, Rossi G, et al. High density lipoprotein cholesterol in coronary artery disease: when higher means later. J Atheroscler Thromb. 2013;20(1):23\u201331.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"4591_CR37","doi-asserted-by":"publisher","first-page":"e713","DOI":"10.1002\/osp4.713","volume":"10","author":"M Fakhrolmobasheri","year":"2024","unstructured":"Fakhrolmobasheri M, Abhari AP, Heidarpour M, Paymannejad S, Pourmahdi-Boroujeni M, Saffari AS, et al. Lipid accumulation product and visceral adiposity index for incidence of cardiovascular diseases and mortality; results from 13 years follow-up in Isfahan cohort study. Obes Sci Pract. 2024;10(1):e713.","journal-title":"Obes Sci Pract"},{"issue":"3","key":"4591_CR38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/cen.12447","volume":"81","author":"II Androulakis","year":"2014","unstructured":"Androulakis II, Kandaraki E, Christakou C, et al. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2014;81(3):426\u201331.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4591_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1476-511X-10-183","volume":"10","author":"MC Amato","year":"2011","unstructured":"Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis. 2011;10:183.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"4591_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10753-010-9193-4","volume":"33","author":"L Zhong","year":"2010","unstructured":"Zhong L, Li Q, Jiang Y, et al. The ApoB\/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population. Inflammation. 2010;33(6):353\u20138.","journal-title":"Inflammation"},{"issue":"1","key":"4591_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12933-022-01670-x","volume":"21","author":"T Qiao","year":"2022","unstructured":"Qiao T, Luo T, Pei H, et al. Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):225.","journal-title":"Cardiovasc Diabetol"},{"key":"4591_CR42","doi-asserted-by":"crossref","unstructured":"Chen HJ, Li GL, Sun A, Peng DS, Zhang WX, Yan YE. Age differences in the relationship between secondhand smoke exposure and risk of metabolic syndrome: A Meta-Analysis. Int J Environ Res Public Health. 2019; 16(8).","DOI":"10.3390\/ijerph16081409"},{"key":"4591_CR43","doi-asserted-by":"crossref","unstructured":"Choi M, Han J, Kim Y, Chung J. The relationship between metabolic syndrome and smoking and alcohol experiences in adolescents from Low-Income households. Child (Basel). 2021; 8(9).","DOI":"10.3390\/children8090812"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04591-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04591-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04591-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T14:32:39Z","timestamp":1741357959000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04591-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4591"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04591-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was an observational study, and the results of the study did not involve the personal characteristics of the patients and did not pose any risk to the patients, so the informed consent of the patients was waived. Clinical trial number: not applicable. This study followed the Declaration of Helsinki. Approved by the Ethics Committee of Hangzhou Hospital of Zhejiang Medical and Health Group (Ls20240005).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}